Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 836 results for "lilly"

Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology
Morningstar.com

BRIEF-Adocia and Lilly teams up to develop ultra-rapid insulin

Dec 19 (Reuters) - Adocia SAS : * Lilly and Adocia announce alliance to co-develop ultra-rapid insulin based on BioChaperone technology * Says total up-front and milestone payments could reach up to $570 million * Lilly and Adocia to develop ... Reuters, 2 hours ago
[x]  

1,110 images for lilly

Business 2 Community, 9 hours ago
Ticker Report, 6 hours ago
Times of India, 21 hours ago
UK E Online, 6 hours ago
UK E Online, 6 hours ago
Collider.com, 15 hours ago
Sunshine Coast Daily, 11 hours ago
Sunshine Coast Daily, 11 hours ago
STV.tv, 43 minutes ago
ClinicSpace, 14 hours ago

Eli Lilly and Adocia agree to develop ultra-rapid insulin

Dec 19 (Reuters) - U.S. drugmaker Eli Lilly and French biotech Adocia said on Friday they agreed a worldwide licensing partnership to develop ultra-rapid insulin to treat patients with Type 1 and Type 2 diabetes. Under the deal, Adocia will ...
 Reuters2 hours ago UPDATE 1-Eli Lilly and Adocia agree to develop fast-acting insulin  Reuters18 minutes ago
[x]  

SmarTrend Watching for Potential Pullback in Shares of Eli Lilly After 3.09% Gain

Eli Lilly (NYSE:LLY) traded in a range yesterday that spanned from a low of $70.91 to a high of $72.48. Yesterday, the shares gained 3.1%, which took the trading range above the 3-day high of $71.35 on volume of 5.8 million shares. Often times ...
 Individual.com10 hours ago Watch for Eli Lilly to Potentially Pullback After Gaining 3.09% Yesterday  Comtex SmarTrend9 hours ago

Next Resistance Level for Eli Lilly (LLY) is $71.54

Shares of Eli Lilly (NYSE:LLY) opened today above their pivot of $70.07 and have already reached the first level of resistance at $70.91. Should the shares continue to rise, the resistance pivots of $71.54 and $73.01 will be
 Individual.com16 hours ago Eli Lilly (LLY) Trading Near $68.64 Support Level  PredictWallStreet2 days ago

Morgan Stanley's Rating Change Only Had Short-term Impact, Eli Lilly Down 1.1% (LLY)

(Financial News Network On) One week ago Eli Lilly (NYSE:LLY) was upgraded from Underweight to Overweight at Morgan Stanley. The shares closed at $70.28, or 1.1% under the $71.05 price of one week ago. Eli Lilly and Company discovers, develops, ...
 Individual.com17 hours ago
The Wrap

The Hobbit Star Orlando Bloom Wants to Make Porno Elven Spinoff (Video)

Legolas actor wants to film with co-stars Evangeline Lilly and Lee Pace using iPhones and GoPros Orlando Bloom s Legolas brought a whole new level of sexiness to Peter Jackson s Lord of the Rings films. So it's no surprise that there was quite ...
 The Wrap1 hour ago The 'Hobbit' Cast Quizzed on Which Co-Stars Are the Funniest, Clumsiest, and Most Likely to Forget Their Lines  Yahoo!1 day ago

Biothera Participates in Cancer Research UK Combinations Alliance

Biothera announced today that it has joined AstraZeneca, Astex Pharmaceuticals, Eli Lilly and Company, MedImmune and Verastem as the latest pharmaceutical partner in Cancer Research UK's Combinations Alliance. The Combinations ...
 Crawford Financial Planning17 hours ago Biothera Joins Cancer Research UK Combinations Alliance  PharmaceuticalProcessing16 hours ago
[x]  

East/West CEO Conference to Feature Prominent CEOs and Other Industry Leaders on January 10th and 11th

Boston Biotech Conferences Invites You to Join John Lechleiter (Eli Lilly), Sue Desmond-Hellmann (Bill & Melinda Gates Foundation), Bob Duggan (Pharmacyclics), Michael Hayden (Teva), Francois Nader (NPS Pharmaceuticals), Stephen Oesterle ...
 Virtual Strategy Magazine19 hours ago
[x]  
ClinicSpace

US FDA approves Lilly' Cyramza in combo with docetaxel to treat patients with NSCLC

Eli Lilly and Company has received its third US Food and Drug Administration (FDA) approval for Cyramza (ramucirumab). Specifically, Cyramza is now also indicated in combination with docetaxel, for the treatment of patients with metastatic ...
 PharmaBiz1 day ago FDA Okays Lilly's CYRAMZA To Treat Non-Small Cell Lung Cancer  RTTNews.com2 days ago Company Update (NYSE:LLY): Lilly Sets Dates and Conference Calls for 2015 Financial Guidance and Fourth-Quarter 2014 Financial Results  MoneyShow.com1 day ago Lilly's lung cancer drug sees FDA approval  Pharmafocus1 day ago
[x]  
Times of India

`Hobbit` star Evangeline Lilly says …

Washington, Dec 18 (ANI): Evangeline Lilly has revealed that writing is her true passion and she even took two years off to be an author after she finished shooting 'The Hobbit'. She said that when she started to work on 'Ant-Man', she was curious ...
 Yahoo! India1 day ago 'Hobbit' star Evangeline Lilly says her true passion is writing  Times of India21 hours ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less